On April 1, 2019, BioSpecifics Technologies Corp. appointed Dr. Ronald Law to the role of Principal Executive Officer of the Company and Mr. Pat Caldwell to the role of Principal Financial Officer, assuming both the principal financial officer and principal accounting officer functions on an interim basis pending an executive search being conducted by the Company. Dr. Law, 66, previously served as Senior Vice President of Business Development of the Company, a position he held since November 2018.

Dr. Law has been consulting for the Company since July 15, 2018. Previously, Dr. Law was the Chief Strategy Officer of Oramed Pharmaceuticals Inc. Mr. Caldwell, 57, has served as a financial advisor and has provided consulting services to the Company since October 2006. Previously, he provided consulting services to his former employer, Protein Design Labs Inc. From February 1992 to April 2005, Mr. Caldwell served as the Vice President of Finance and Controller of PDL.